scispace - formally typeset
M

Marie Paule Schneider

Researcher at University of Lausanne

Publications -  67
Citations -  1203

Marie Paule Schneider is an academic researcher from University of Lausanne. The author has contributed to research in topics: Medicine & Pharmacy. The author has an hindex of 13, co-authored 53 publications receiving 967 citations. Previous affiliations of Marie Paule Schneider include University of Geneva.

Papers
More filters
Journal ArticleDOI

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions

TL;DR: It is suggested that objective monitoring of compliance using electronic devices may be a useful step in the management of patients with refractory hypertension, as it enables physicians to take rational decisions based on reliable and objective data of drug compliance and hence to improve blood pressure control.
Journal ArticleDOI

Assessing medication adherence: options to consider

TL;DR: A multitude of indirect measures of adherence exist in the literature, however, there is no “gold” standard for measuring adherence to medications and future research and practice interventions should use an internationally accepted, operational standardized definition of medication adherence.
Journal ArticleDOI

Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies

TL;DR: A fairly high prevalence of swallowing difficulties in polypharmacy patients attending their community pharmacies is reported, with intentional non adherence and altering the oral dose formulation were the most common and potentially harmful strategies used by patients to overcome their swallowing difficulties.
Journal ArticleDOI

Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.

TL;DR: Self-report of two or more missed doses of ART is associated with an increased risk of both viral failure and death, and a simple adherence question helps identify patients at risk for negative clinical outcomes and offers opportunities for intervention.
Journal ArticleDOI

Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring.

TL;DR: Overall, practicability and acceptability of the IDAS II and the MEMS device were similar and could be a useful tool for the management of long-term therapies.